891 related articles for article (PubMed ID: 22435452)
1. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2013 Apr; 8(4):411-26. PubMed ID: 23373617
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
An L; Liu R; Tang W; Wu JG; Chen X
Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
[TBL] [Abstract][Full Text] [Related]
5. A cell-based screening system for influenza A viral RNA transcription/replication inhibitors.
Ozawa M; Shimojima M; Goto H; Watanabe S; Hatta Y; Kiso M; Furuta Y; Horimoto T; Peters NR; Hoffmann FM; Kawaoka Y
Sci Rep; 2013; 3():1106. PubMed ID: 23346363
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
Hagiwara K; Kondoh Y; Ueda A; Yamada K; Goto H; Watanabe T; Nakata T; Osada H; Aida Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):721-7. PubMed ID: 20230782
[TBL] [Abstract][Full Text] [Related]
7. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
[TBL] [Abstract][Full Text] [Related]
8. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
9. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
[TBL] [Abstract][Full Text] [Related]
10. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
11. Recent discoveries of influenza A drug target sites to combat virus replication.
Patel H; Kukol A
Biochem Soc Trans; 2016 Jun; 44(3):932-6. PubMed ID: 27284062
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
13. Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Mol Biosyst; 2012 Apr; 8(4):1297-303. PubMed ID: 22307679
[TBL] [Abstract][Full Text] [Related]
14. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
Yeh JY; Coumar MS; Horng JT; Shiao HY; Kuo FM; Lee HL; Chen IC; Chang CW; Tang WF; Tseng SN; Chen CJ; Shih SR; Hsu JT; Liao CC; Chao YS; Hsieh HP
J Med Chem; 2010 Feb; 53(4):1519-33. PubMed ID: 20092255
[TBL] [Abstract][Full Text] [Related]
15. High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses.
Mudhasani R; Kota KP; Retterer C; Tran JP; Tritsch SR; Zamani R; Whitehouse CA; Bavari S
J Biomol Screen; 2015 Jan; 20(1):141-52. PubMed ID: 25342145
[TBL] [Abstract][Full Text] [Related]
16. Emerging cellular targets for influenza antiviral agents.
Müller KH; Kakkola L; Nagaraj AS; Cheltsov AV; Anastasina M; Kainov DE
Trends Pharmacol Sci; 2012 Feb; 33(2):89-99. PubMed ID: 22196854
[TBL] [Abstract][Full Text] [Related]
17. Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions.
Chase G; Wunderlich K; Reuther P; Schwemmle M
Methods; 2011 Oct; 55(2):188-91. PubMed ID: 21867756
[TBL] [Abstract][Full Text] [Related]
18. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
Vasou A; Paulus C; Narloch J; Gage ZO; Rameix-Welti MA; Eléouët JF; Nevels M; Randall RE; Adamson CS
Antiviral Res; 2018 Feb; 150():79-92. PubMed ID: 29037975
[TBL] [Abstract][Full Text] [Related]
19. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection.
Komatsu T; Kido N; Sugiyama T; Yokochi T
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):1-7. PubMed ID: 22856509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
